VIVS
VivoSim Labs, Inc.
NASDAQ: VIVS · HEALTHCARE · BIOTECHNOLOGY
$1.44
-3.36% today
Updated 2026-04-29
Market cap
$4.34M
P/E ratio
0.85
P/S ratio
30.58x
EPS (TTM)
$1.76
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
VivoSim Labs, Inc. (VIVS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-10,577.00%
ROE
-51.10%
ROA
-132.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-147817.00 | — | — | — |
| 2013 | $1.20M | $-43.55M | 100.00% | -778.53% | -3,638.51% |
| 2014 | $379000.00 | $-25.85M | 100.00% | -5,448.28% | -6,820.05% |
| 2015 | $571000.00 | $-30.08M | 100.00% | -5,305.95% | -5,268.30% |
| 2016 | $1.48M | $-38.58M | 100.00% | -2,605.73% | -2,601.15% |
| 2017 | $4.23M | $-38.45M | 77.40% | -911.94% | -908.91% |
| 2018 | $4.60M | $-34.80M | 77.62% | -766.26% | -756.09% |
| 2019 | $3.09M | $-26.64M | 84.41% | -882.37% | -861.70% |
| 2020 | $2.20M | $-18.71M | 85.06% | -977.91% | -852.00% |
| 2021 | $0.00 | $-16.83M | — | — | — |
| 2022 | $1.50M | $-11.45M | 100.00% | -765.27% | -763.20% |
| 2023 | $370000.00 | $-17.26M | 100.00% | -4,792.16% | -4,664.59% |
| 2024 | $109000.00 | $-14.67M | 100.00% | -13,840.37% | -13,459.63% |
| 2025 | $144000.00 | $-2.49M | 96.53% | -8,761.11% | -1,727.78% |